AMB-FUBINACA
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1715016-76-4 |
| ChemSpider | 32055540 |
| Chemical data | |
| Formula | C21H22FN3O3 |
| Molar mass | 383.41 g/mol |
| |
| |
AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is presumed to be an agonist of the CB1 receptor and has been sold online as a designer drug.[1]
Legal status
The state of Louisiana banned AMB-FUBINACA through an emergency rule after it was detected in a synthetic cannabis product called "Train Wreck 2" which had been linked to adverse events and seizures on 3 June 2014.[2]
Sweden's public health agency suggested classifying AMB-FUBINACA as hazardous substance on November 10, 2014.[3]
See also
References
- ↑ "FUB-AMB". Cayman Chemical. Retrieved 21 July 2015.
- ↑ "DHH Adds Two New Synthetic Marijuana Compounds to Banned List". Louisiana Department of Health and Hospitals. 3 June 2014. Retrieved 21 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 21 July 2015.
This article is issued from Wikipedia - version of the Wednesday, March 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
